Trade Summary

1 week ago, Sullivan Louis W, serving as Dir at United Therapeutics Corp (UTHR), sold 5,950 shares at $512.14 per share, for a total transaction value of $3,047,201.00. Following this transaction, Sullivan Louis W now holds 3,200 shares of UTHR.

This sale represents a 65.00% decrease in Sullivan Louis W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 22, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 23, 2025, 1 day after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.